Skip NavigationSkip to Content
Return Return to Search Results

Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent

  1. Author:
    Warfield, K. L.
    Swenson, D. L.
    Olinger, G. G.
    Kalina, W. V.
    Viard, M.
    Aitichou, M.
    Chi, X.
    Ibrahim, S.
    Blumenthal, R.
    Raviv, Y.
    Bavari, S.
    Aman, M. J.

  2. Author Address

    Integrat BioTherapeut Inc, Frederick, MD 21704 USA. USA, Med Res Inst Infect Dis, Ft Detrick, MD USA. NCI, Ctr Canc Res Nanobiol Program, Frederick, MD 21701 USA. NCI, Sci Appl Int Corp, Basic Program, Frederick, MD 21701 USA.;Aman, MJ, Integrat BioTherapeut Inc, 4539 Metropolitan Ct, Frederick, MD 21704 USA.;javad@integratedbiotherapeutics.com
    1. Year: 2007
    2. Date: Nov
  2. Journal: Journal of Infectious Diseases
    1. 196
    2. Pages: S276-S283
  4. Type of Article: Article
  5. ISSN: 0022-1899
  1. Abstract:

    Current methods for inactivating filoviruses are limited to high doses of irradiation or formalin treatment, which may cause structural perturbations that are reflected by poor immunogenicity. In this report, we describe a novel inactivation technique for Zaire Ebola virus (ZEBOV) that uses the photoinduced alkylating probe 1,5-iodonaphthylazide (INA). INA is incorporated into lipid bilayers and, when activated by ultraviolet irradiation, alkylates the proteins therein. INA treatment of ZEBOV resulted in the complete loss of infectivity in cells. Results of electron microscopy and virus-capture assays suggested the preservation of conformational surface epitopes. Challenge with 50,000 pfu of INA-inactivated, mouse-adapted ZEBOV did not cause disease or death in mice. A single vaccination with INA-inactivated ZEBOV (equivalent to 5 X 10(4)pfu) protected mice against lethal challenge with 1000 pfu of ZEBOV. INA- inactivated virus induced a protective response in 100% of mice when administered 3 days before challenge. Thus, INA may have significant potential for the development of vaccines and immunotherapeutics for filoviruses and other enveloped viruses.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1086/520605
  3. View record in Web of Science®
  4. WOS: 000251090400024

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel